Connectyx Announces an Exclusive MedFlash ResellerAgreement with United Drugs. PALM CITY, Fla. -- Ronn Schuman, CEO of Connectyx Technologies (Pink Sheets:CTYX), announced it has signed a definitive exclusive endorsement agreement with United Drugs, a privately held company, to take its MedFlash PHR (Personal Health Record) device to its over 1000 independent pharmacies nationally. "United Drugs affords MedFlash the opportunity to penetrate the sizable independent pharmacy network on a national scale. Neighborhood pharmacies in both rural and urban areas are one stop health centers who go the extra mile to bring the best health services to their customers," states Ronn Schuman.
Elizabeth Schrader of United Drugs states, "The MedFlash PHR device is of critical importance to the customers of our member pharmacies. To have your personal medical records available in an emergency can be a life saving device. "
About Connectyx - www.connectyx.com, www.mrnmanager.com, www.med-flash.com
Connectyx Technologies is a publicly held company that provides business and consumer intelligent software, which provides technical excellence, innovation, and performance.
About United Drugs:
United Drugs is a cooperative of independent pharmacists-neighbors who own their own business and who care about you and your community because it's their community too. Over 32 years ago, a few independent pharmacists created a cooperative that provides buying power and contractual services to its members. The cooperative has since grown to over 1000 pharmacies across the nation.
This press release contains forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are subject to risks and uncertainties, which could cause actual results to differ materially from those anticipated. Such risks and uncertainties include, but are not limited to, rules and regulations promulgated under the Act, unanticipated changes in Medicare reimbursement, outcomes of government reviews, inquiries and investigations and related litigation, continued compliance with government regulations, fluctuations in customer demand, management of rapid growth, competition from other healthcare product vendors, timing and acceptance of new product introductions, general economic conditions, geopolitical events and regulatory changes, as well as other relevant risks. The information set forth herein should be read in light of such risks. Connectyx assumes no obligation to update the information contained in this press release.
